CD8A and non-small cell lung carcinoma: This study provides evidence suggesting that the IFNγ-mediated JAKs-STATs axis plays a double-edged sword in NSCLC stimulating reactivation of CD8+ T cells but increasing anti-apoptosis MCL1 expression in A549.